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An in vitro system is described which supports the synthesis of vesicular
stomatitis virus (VSV) negative-strand RNA. The major components of this
system are (i) an mRNA-dependent rabbit reticulocyte lysate to carry out cell-free
protein synthesis, (ii) the five VSV mRNAs to program VSV-specific protein
synthesis, and (iii) nucleocapsids containing positive- and negative-strand
genome-length RNA. The protein products synthesized in the system in response
to addition of saturating amounts of the five VSV mRNA's included polypeptides
which comigrated in acrylamide gels with the five VSV proteins. Approximately
200 pmol of protein per ml was synthesized during a 90-min reaction. The RNA
products synthesized in the system included all five of the VSV mRNA's and, in
addition, negative-strand, genome-sense RNA. All of the negative-strand RNA,
which represented 2 to 5% of the total RNA product synthesized in vitro, banded
in CsCl at the position of nucleocapsids. All of the mature mRNA's made in the
system pelleted in CsCl. This technique allowed a clear separation of negative-
strand product from the mRNA products and facilitated further analysis of the
negative-strand product. The amount of negative-strand product produced in the
system was shown to be a function of the amount of concurrent protein synthesis
in the system. An increase in the level of protein synthesis led to an increase in the
amount of negative-strand RNA synthesized, whereas inhibition of protein
synthesis by cycloheximide resulted in a 70% inhibition of negative-strand
synthesis. In contrast to the negative-strand RNA product, the amount of
transcriptive product was decreased by 50o in the presence of maximum levels of
viral protein synthesis. This inhibition was reversed by adding cycloheximide.
Characterization of the negative-strand product by Northern blot analysis demon-
strated that negative-strand product was being synthesized which hybridized to all
five of the VSV mRNA's and, hence, that product representing all of the VSV
cistrons was being made. This in vitro system offers an opportunity to study
factors involved in the promotion of VSV genome replication as well as those
responsible for the regulation of transcription.
The negative-strand RNA virus vesicular sto-
matitis virus (VSV) carries out two distinct RNA
synthetic processes. One process, transcription,
is the synthesis of RNAs that are complemen-
tary to the genome and include a 47-base leader
RNA and five individual mRNA's (5, 7, 17). The
other RNA synthetic process is that of genome
replication, in which a complete genome-length
complementary (VC) RNA is made and then
functions as template for the replication of prog-
eny negative-strand RNAs (16, 18). The two
processes are clearly distinguished on the basis
of their requirements for protein synthesis.
Transcription can occur in the absence of pro-
tein synthesis, whereas replication requires con-
current protein synthesis (10, 20). If protein
synthesis is inhibited at any stage during VSV
infection, even at late times when replication is
established, the production of progeny genomes
is rapidly inhibited whereas the synthesis of the
complementary mRNA's not only continues but
continues at an increased rate (20).
The transcription process has been repro-
duced in highly purified in vitro systems, and
reconstitution experiments executed in these
systems have shown that three virion proteins
are required for transcription (9, 13). These
proteins are N, the nucleocapsid structural pro-
tein, L, one component of the RNA-dependent
RNA polymerase, and NS, a phosphoprotein.
This work has also shown that the active tem-
plate for VSV RNA synthesis is not free viral
RNA but RNA coated with the N protein in an
RNase-resistant nucleocapsid structure (8). In
contrast to these studies of transcription, direct
studies of the requirements for replication have
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not been possible because a cell-free, in vitro
system for the synthesis of VSV genome RNA
has not been described.
In this communication we describe a cell-free,
in vitro system which supports the synthesis of
VSV negative-sense RNA. This study has fo-
cused on the second step in replication only, that
is, the synthesis of progeny negative-strand
RNA from the genome-size, positive-strand
RNA template. This has been done to use RNA-
RNA hybridization as a specific assay for repli-
cative events against the background of tran-
scriptive events.
In designing a system to support negative-
strand RNA synthesis, we accommodated the
two requirements for this process previously
identified by studies of replication in infected
cells, namely, (i) a source of continuous viral
protein synthesis and (ii) the appropriate tem-
plate for this process, the genome-size, plus-
strand RNA in a nucleocapsid structure. Specifi-
cally, the components of the system include (i)
an mRNA-dependent rabbit reticulocyte lysate,
(ii) purified VSV mRNA's which are used to
program protein synthesis in the reticulocyte
lysate, and (iii) nucleocapsids containing both
positive- and negative-strand RNA to serve as
the templates for RNA synthesis. This report
describes this in vitro system for the synthesis of
negative-strand RNA and the initial character-
ization of its protein and RNA products. Addi-
tionally, this work shows that replication in this
system is sensitive to the levels of attendant
protein synthesis and thereby reflects an impor-
tant characteristic of authentic VSV genome
synthesis. Results presented here also show that
the balance between levels of replicative and
transcriptive events in the system are altered as
a function of protein synthesis in the system.
MATERIALS AND METHODS
Celi cultures and virus. Monolayers of a continuous
line of baby hamster kidney cells (BHK-21/13) were
grown in Eagle minimal essential medium containing
5% heat-inactivated calf serum. The Indiana serotype
of VSV was propagated in BHK cells as described
previously (20). Cells were infected at an input multi-
plicity of 2 to 4 PFU per cell and incubated at 37°C in
the presence of 4 ,ug of actinomycin D per ml. At 5 h
postinfection, infected monolayers were harvested as
described below for isolation of either mRNA or
intracellular nucleocapsids.
Preparation of purified VSV mRNA's. At 5 h postin-
fection, VSV-infected BHK cells were suspended in
HBS solution (10 mM N-2-hydroxyethylpiperazine-
N'-2-ethanesulfonic acid (HEPES), pH 7.6, 10 mM
NaCI, 1 mM MgCl2) and broken by Dounce homogeni-
zation. Nuclei were removed by centrifugation at
2,000 x g. The supernatant was made approximately
4.5 M with respect to CsCl and 1.5% in N-lauryl
sarcosine and was layered over 2 ml of 5.7 M CsCl
solution containing HBS, 0.1 M EDTA, and 2% N-
lauryl sarcosine. After 12 to 24 h of centrifugation in a
Beckman SW40 rotor at 25,000 rpm and 22°C, the clear
RNA pellet was resuspended in sterile water, brought
to 0.2 M NaCI-0.2% sodium dodecyl sulfate (SDS),
and ethanol precipitated. After a second precipitation
with ethanol, mRNA's were isolated by binding to and
elution from oligodeoxythymidylate [oligo(dT)]-cellu-
lose in 0.01 M Tris-hydrochloride, pH 7.5, containing
0.02% SDS. Eluted mRNA's were precipitated with
ethanol after addition of rabbit liver tRNA carrier and
NaCl to 0.2 M. Before use in the in vitro system, the
RNA was precipitated with ethanol out of 0.2 M
potassium acetate with no SDS.
Preparation of nucleocapsids. At 5 h postinfection,
actinomycin-treated, VSV-infected BHK cells were
suspended in 3.3 mM Tris-hydrochloride, pH 8.5, 3
mM NaCI, and 1.5 mM MgCl2 and broken by Dounce
homogenization. Nuclei and large cell debris were
removed by centrifugation. In some cases, a high-
speed pellet fraction containing viral nucleocapsids as
well as viral polysomes, cellular membrane structures,
and other organelles was prepared by centrifugation in
a Beckman SW50.1 rotor at 35,000 rpm for 1 h at 4°C.
The pellet was gently resuspended in 10 mM HEPES,
pH 7.7, 2 mM dithioerythritol, and 10% glycerol. In
other experiments the intracellular nucleocapsids were
partially purified as follows. The lysed cells were
centrifuged at 10,000 x g for 10 min, the pellet was
rehomogenized in fresh buffer and centrifuged, and the
two 10,000 x g supernatants were combined. In a
siliconized tube, Tris-hydrochloride, pH 8.1, was add-
ed to 50 mM, CaCl2 was added to 1 mM, and micro-
coccal nuclease was added to 10 ,ug/ml. After 10 min of
incubation at 23°C, the nuclease activity was inhibited
by addition of 2 mM ethylene glycol-bis(3-aminoethyl
ether-N,N-tetraacetic acid (EGTA), and the nucleo-
capsids were sedimented through a 3-ml 15 to 30%o (wt/
vol) sucrose gradient containing 3 mM Tris-hydrochlo-
ride, pH 8, 3 mM MgC92, 66 mM NH4C1, 14 mM KCI,
and 2 mM dithioerythritol in a Beckman SW50.1 rotor
for 2 h at 45,000 rpm and 4°C. The pellet was gently
resuspended and added to the in vitro system as
indicated below.
Reticulocyte lysate preparation. Reticulocytes from a
single rabbit were purchased from Green Hectares
(Oregon, Wis.) and lysed with an equal volume of
water. The lysates were clarified by centrifugation at
17,000 x g for 10 min, and the supernatants were
stored in small portions at -70°C. Immediately before
use, the lysate was thawed, brought to 20 mM Tris-
hydrochloride, pH 8.1, 50 jig of creatine phosphoki-
nase per ml, 1 mM CaC12, 30 ,uM hemin, and 10 1Lg of
micrococcal nuclease per ml, and was incubated for 10
min at 23°C. EGTA was then added to a concentration
of 2 mM (14).
In vitro synthesis of vWiral RNA and proteins. The
components of the system for VSV RNA synthesis
were combined in a final volume of 50 ,ul to give the
following concentrations: micrococcal nuclease-treat-
ed rabbit reticulocyte lysate, 70% by volume; purified
viral mRNA's, approximately 100 ,ug/ml; nucleocap-
sids, 12 to 20%o by volume; HEPES, pH 7.6, 50 mM;
creatine-phosphate, 10 mM; ATP, 1 mM; GTP, 0.6
mM; CTP, 0.6 mM; UTP, 0.1 mM; a mixture of 20
amino acids, each at 0.05 mM; magnesium acetate, 2
mM; dithioerythritol, 2 mM; ammonium chloride, 66
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mM; potassium acetate, 14 mM; and rabbit liver
tRNA, 50 to 60 ,ug/ml.
Viral proteins were labeled with [35S]methionine in
reaction mixtures in which the concentration of unla-
beled methionine was reduced to 12.5 F.M and to
which 3 to 5 ,uCi of [35S]methionine was added. Viral
RNA was labeled in vitro by adding [3H]UTP (1 mCi/
ml) or [a-32P]UTP (0.5 to 0.7 mCi/ml) to the complete
reaction mixture. The reactions were incubated at
30°C, and the synthesis of RNA or proteins was
assayed by counting radioactivity present in a tri-
chloroacetic acid precipitate of 1- to 2-,ul samples
removed during the incubation. 35S-labeled samples
were heated to 95°C for 15 min in 5% trichloroacetic
acid before processing to destroy 35S-labeled methio-
nine tRNA. Acrylamide gel electrophoresis of 35S5
labeled protein products was performed by use of an
SDS-containing 7.5 to 18% gradient polyacrylamide
slab gel as described previously (2, 7a). 3H- or 32P-
labeled RNA products were purified by phenol extrac-
tion and were electrophoresed on 1.5% agarose gels
containing 6 M urea (19).
Analysis of reaction products by centrifugation in
CsCI gradients. In vitro reaction mixtures were diluted
into 2.5 ml of a solution containing 3.3 mM Tris, pH
8.5, 3 mM NaCl, 1.5 mM MgCl2, and 0.5% Nonidet P-
40 detergent in siliconized tubes. The solution was
pipetted onto a 1.5-ml layer of 5% sucrose covering an
8-ml preformed gradient of 20 to 40% (wt/wt) CsCl.
The gradient was centrifuged in a Beckman SW40
rotor at 35,000 rpm for 14 to 16 h at 4°C. Gradients
were fractionated by removing 0.5-ml portions from
the top. The visible nucleocapsid band was removed
and transferred to a siliconized tube. The pellet was
resuspended in 0.5 ml of 10 mM Tris-hydrochloride,
pH 7.4. The distribution of 3H- or 32P-labeled RNA
products was determined by trichloroacetic acid pre-
cipitation and scintillation counting of samples of the
fractions.
A portion of the nucleocapsid-containing fraction
was diluted approximately 30-fold into 2x SSC (0.3 M
sodium chloride, 0.03 M sodium citrate) for assay of
RNase resistance as follows. Identical samples were
diluted either into 2x SSC and immediately trichloro-
acetic acid precipitated or were diluted into 2x SSC
containing 25 pug of pancreatic RNase per ml, incubat-
ed at 23°C for 30 min, and then trichloroacetic acid
precipitated. The remaining CsCl-banded product was
desalted by chromatography on Sephadex G-25, phe-
nol extracted, and ethanol precipitated. The purified
CsCl-banded RNA was then used in hybridization
experiments with unlabeled VSV virion RNA or
mRNA's (18).
Affinity chromatography of reaction products on oli-
go(dT)-cellulose. Reaction products labeled with [a-
2P]UTP were solubilized in 1% SDS and extracted
with phenol. After precipitation with ethanol, the
RNA was dissolved in 10 mM Tris-hydrochloride, pH
7.4, 1 mM EDTA, and 0.2% SDS, heated at 100°C for
90 s, chilled, and brought to 0.4M NaCl. After passage
through oligo(dT)-cellulose, the unbound products
were diluted to give 0.2 M NaCl and were precipitated
with ethanol. The bound RNAs were eluted with 10
mM Tris-hydrochloride-0.02% SDS and ethanol pre-
cipitated. Recovery ofRNA products was 90 to 100lo,
and 40%o of the acid-insoluble RNA product was
recovered in the unbound fraction. This nonadenylat-
ed fraction, which contained all of the negative-strand
RNA product, was incubated in 0.2 N NaOH-0.1 N
NaCl for 15 min at 4°C, neutralized with 1 M HEPES,
and used to probe Northern blots of electrophoretical-
ly separated unlabeled VSV mRNA's immobilized on
diazobenzyloxymethyl paper (1, 19a).
Materials. Micrococcal nuclease was purchased
from Sigma Chemical Co. Rabbit liver tRNA (Sigma)
was phenol extracted and precipitated with ethanol
before use. Oligo(dT)-cellulose was purchased from
Bethesda Research Laboratories. [3H]UTP and [a-
32P]UTP were obtained from New England Nuclear,
and [35S]methionine, from Amersham Corp.
RESULTS
Components of the in vitro system. The synthe-
sis of genome RNA in the VSV system requires
ongoing protein synthesis. Therefore, a primary
consideration in establishing a cell-free, in vitro
system for genome RNA synthesis was to pro-
vide an efficient, continuous source of VSV
proteins. Rabbit reticulocyte lysates can be
made mRNA dependent by treatment with mi-
crococcal nuclease. These lysates then synthe-
size proteins efficiently when programmed with
exogenous mRNA's (14). Saturating amounts of
VSV mRNA's were added to the mRNA-depen-
dent lysates to program viral protein synthesis.
The kinetics and products of this reaction will be
described in detail below.
The second major consideration in establish-
ing an in vitro system was the provision of the
appropriate template for the replication process.
The establishment of a system whose goal was
the synthesis of negative-strand RNA made it
necessary to provide the genome-size, positive-
strand RNA in the form of a nucleocapsid. Since
positive-strand nucleocapsids exist only in the
infected cell (16), intracellular nucleocapsids
were isolated for use as templates in this system.
Thus, by programming the system with positive-
strand as well as negative-strand templates, it
was expected that progeny negative-strand RNA
could be synthesized directly from the positive-
strand templates. Therefore, these experiments
do not require that the system first make a
complete positive-strand nucleocapsid template
for the synthesis of negative-strand RNA.
It was our aim to design a system that could be
made dependent on protein synthesis pro-
grammed by addition of VSV mRNA's to the
messenger-dependent reticulocyte lysate.
Therefore, it was necessary to devise a method
for separating the intracellular nucleocapsid
templates from contaminating cellular debris
and, in particular, any viral mRNA's or polyri-
bosomes which our early experiments demon-
strated could copurify with the nucleocapsids.
This was accomplished by treating cytoplasmic
extracts from VSV-infected cells with micrococ-
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cal nuclease in the presence of calcium and then
inactivating the nuclease by addition of EGTA.
This treatment digests mRNA's (14). The
genome-size VSV RNAs, however, are present
in the cytoplasm only as protein-coated nucleo-
capsids and were thus protected from digestion
by this enzyme under the conditions used (see
below and Fig. 1).
The nucleocapsids present in the micrococcal
nuclease-treated extract were concentrated and
separated from soluble cellular components by
pelleting through a 15 to 30% sucrose gradient.
Nucleocapsids prepared in this manner were
compared with untreated control nucleocapsids
and found to cosediment in a 15 to 30% sucrose
gradient (data not shown). A comparison of the
RNA present in nucleocapsid preparations made
either with or without micrococcal nuclease
treatment is shown in Fig. 1. Only RNA that
comigrates in an agarose-urea gel with marker
virion RNA is present in the treated preparation
(Fig. 1, lane 3). In contrast, in the untreated
preparation viral mRNA's are also present
which, presumably, have pelleted with the nu-
cleocapsids as polysomes (Fig. 1, lane 2). Analy-
ses of the polarity of the RNA in the treated
nucleocapsid preparation showed approximately
15% positive-strand and 85% negative-strand
RNA. Comparison of the levels of [3H]UTP
incorporation programmed by parallel prepara-
tions of micrococcal nuclease-treated and un-
treated templates in the in vitro system showed
no loss ofRNA synthetic activity after nuclease
treatment. These results showed that this proce-
dure for the preparation of intracellular nucleo-
capsids yields intact genome-length templates
with full enzymatic activity which are free from
viral mRNA molecules.
Protein synthesis. The kinetics of protein syn-
thesis in the in vitro system were assayed by
incorporation of [35S]methionine into acid-insol-
uble material (Fig. 2). Reaction mixtures con-
taining the mRNA-dependent reticulocyte ly-
sates to which 60 to 120 ,ug of purified VSV
mRNA's per ml and the intracellular nucleocap-
sid templates had been added gave a nearly
linear incorporation rate for 90 min at 30°C (Fig.
2, curve A). Addition of this amount of mRNA
gave up to a 50-fold stimulation of [35S]methio-
nine incorporation as compared with a reaction
without added mRNA. These conditions result
in the synthesis of an estimated 10 pmol of viral
protein during 90 min in a 50-pl reaction. Addi-
tion of cycloheximide (or omission of templates
and purified mRNA's, data not shown) to the
reaction resulted in 97% inhibition of [35S]me-
thionine incorporation (Fig. 2, curve C).
The nuclease-treated templates, when added
to the reaction in the absence of VSV mRNA's,







FIG. 1. Agarose-urea gel electrophoresis of tem-
plate RNA. Micrococcal nuclease-treated intracellular
nucleocapsids were prepared as described in Materials
and Methods from VSV-infected BHK cells which had
been labeled with 10 ,Ci of [3H]uridine per ml be-
tween 4 and 5 h postinfection. An untreated control
was prepared from the identical 10,000 x g superna-
tant to which micrococcal nuclease was not added.
The RNAs present in the control and treated nucleo-
capsid pellets were purified by phenol extraction,
precipitated with ethanol, and analyzed by electropho-
resis in a 1.5% agarose gel containing 6 M urea and
0.025 M sodium citrate, pH 3.0 (19). The gel was
processed by fluorography as described (19). Lane 1:
3H-labeled VSV total intracellular RNA marker. Lane
2: RNA in untreated nucleocapsid pellet. Lane 3: RNA
in nucleocapsid pellet treated with micrococcal nucle-
ase (10 ,ug/ml) for 10 min at 23°C.
during the first 30 min of incubation (Fig. 2,
curve B). However, the rate of protein synthesis
began to increase in this reaction after 30 min,
and by 90 min the amount of protein synthesized
reached a level that was approximately 50o of
that made in the complete reaction mixture.
To determine what viral proteins were made
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MINUTES AT 30
N protein was detectable; at 30 min, small
amounts of NS and M proteins were detectable
in addition to increased levels of N protein. By
90 min, a band at the position of the G protein
precursor was visible (data not shown). We
interpret this finding as showing that newly
synthesized mRNA's made in the system are
functional and that, in the absence of added
mRNA, protein synthesis can be programmed
by these new transcripts.
RNA synthesis. The kinetics ofRNA synthesis
in the in vitro system as assayed by incorpo-
ration of [3H]UTP into acid-insoluble material
are shown in Fig. 4. The highest levels of RNA
synthesis were obtained in a reaction mixture
containing nucleocapsid templates and the
mRNA-dependent reticulocyte lysate to which
no exogenous mRNA was added (Fig. 4, curve
A). RNA synthesis was completely dependent
on the presence of templates which, when added
NS'll_
Nl-
FIG. 2. Kinetics of in vitro protein synthesis. Re-
action mixtures (25 ,ul) were adjusted to contain 12.5
IpM methionine, 50 p.M of the remaining 19 amino
acids, and 3 to 5 p,Ci of [35S]methionine, and were
incubated at 30°C. At various times during the incuba-
tion, 2-,ul samples were diluted into 10 mM Tris, pH
7.4,0.2 M NaCl, 1 mM EDTA, and 1% SDS, and were
trichloroacetic acid precipitated. Samples were heated
in 5% trichloroacetic acid at 95°C for 15 min to
hydrolyze "'S-labeled tRNA, collected onto glass-fiber
ifiters, and assayed for I'S counts per minute by liquid
scintillation spectroscopy. Total counts per minute of
[35S]methionine incorporated in 25 p1 is plotted versus
time. Reaction mixtures contained: (A) mRNA-depen-
dent reticulocyte lysate, intracellular nucleocapsid
templates, and purified VSV mRNA's; (B) reticulo-
cyte lysate and nucleocapsid templates; and (C) same
as in A, with cycloheximide (100 ,ug/ml).
dition of the five purified VSV mRNA's, poly-
peptides were labeled with [35S]methionine and
analyzed by SDS-acrylamide gradient gel elec-
trophoresis. Polypeptides synthesized in a reac-
tion mixture containing the mRNA-dependent
reticulocyte lysate and the five mRNA's are
shown in Fig. 3. They include the VSV M, N,
and NS proteins, two polypeptides which mi-
grate in the region of precursors of G protein,
and a high-molecular-weight protein which co-
migrates with the virion L protein. This result
demonstrates that this system for translation of
VSV proteins supports the synthesis of proteins
which comigrate with each of the five viral
polype3ptides.
The 15S-labeled protein products synthesized
in a reaction mixture containing reticulocyte
lysate plus nucleocapsid templates with no add-
ed mRNA were analyzed by SDS-polyacryl-
amide gel electrophoresis after various times of
incubation. After 15 min, only a small amount of
MI
FIG. 3. SDS-acrylamide gradient gel electrophore-
sis of protein products. A reaction mixture containing
the mRNA-dependent reticulocyte lysate, purified
VSV mRNA's, and (35S]methionine was incubated as
described in Fig. 2 for 90 min. A 2-p. portion of the 25-
reaction mixture was diluted into sample buffer
containing 2% SDS and 0.1 m dithioerythritol, heated
at 100°C for 2 min, and electrophoresed in an SDS-
containing 7.5 to 18% gradient polyacrylamide gel
cross-linked with N,N'-diallyltartardiamide (2, 7a).
The stacking gel and discontinuous buffer system were
as described by Laemmli (11). The gel was assayed by
fluorography. The positions of the five VSV proteins
were determined by electrophoresis of "4C-amino
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FIG. 4. Kinetics of in vitro RNA synthesis. Reac-
tion mixtures (50 ,ul) containing 50 ,uCi of [3H]UTP
were incubated at 30°C. At various times during the
incubation, 2-,ul samples were diluted into SDS-con-
taining buffer as in Fig. 2 and immediately precipitated
with 5% trichloroacetic acid. Precipitates were collect-
ed onto glass-fiber filters and assayed for 3H counts
per minute. Total 3H counts per minute incorporated
in 50 ,ul is plotted versus time. (A) A reaction mixture
containing the mRNA-dependent reticulocyte lysate
and intracellular nucleocapsid templates; (B) a reac-
tion mixture as in A, but containing 100 ,ug of VSV
mRNA per ml and 100 ,ug of cycloheximide per ml; (C)
a reaction mixture as in A, but containing 100 ,ug of
VSV mRNA per ml; (D) a reaction mixture as in A, but
without intracellular nucleocapsids.
to the reaction, directed a rapid rate of RNA
synthesis for at least 90 min. The addition of the
VSV mRNA's to the system containing the
nucleocapsid templates and the mRNA-depen-
dent reticulocyte lysate to promote high levels of
protein synthesis at early times led, reproduci-
bly, to a 30 to 50% reduction in the rate ofRNA
synthesis (Fig. 4, curve C) as compared with the
reaction to which no mRNA was added (Fig. 4,
curve A). Addition of equivalent amounts of
mRNA from uninfected cells did not show this
inhibitory effect on RNA synthesis (data not
shown). When the translation of the added
mRNA's was inhibited by the addition of cyclo-
heximide to the system, the amount of total
RNA synthesis reached an intermediate level
(Fig. 4, curve B).
RNA products were analyzed by electropho-
resis in 1.5% agarose gels containing 6 M urea.
As shown in Fig. 5, the predominant products
were the five VSV mRNA's, which comigrated
with mature mRNA's synthesized in the VSV-
infected cell. In addition to the mRNA's, 3H-
labeled product was also present which migrated
in the region of genome-length RNA. A product





FIG. 5. Agarose-urea gel electrophoresis of RNA
products. RNAs synthesized in cell-free reaction mix-
tures containing [3H]UTP were purified by phenol
extraction and analyzed by electrophoresis in 1.5%
agarose gels containing 6 M urea (19). 3H-labeled
RNAs were visualized by fluorography of the dried
gel. Lane 1: 3H-labeled total viral RNA from infected
cells. Lane 2: 3H-labeled RNA products of a reaction
mixture containing reticulocyte lysate without intra-
cellular nucleocapsid templates. Lane 3: 'H-labeled
RNA products of a reaction mixture which included
mRNA-dependent reticulocyte lysate and a nucleo-
capsid-containing high-speed pellet from infected
cells. Lane 4: 3H-labeled RNA products of a reaction
mixture identical to that used for lane 3 except that
purified viral mRNA's were added to program protein
synthesis.
J. VIROL.
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base leader RNA was also observed when the
products were analyzed by electrophoresis on a
15% acrylamide gel (data not shown). Denatur-
ation of RNA products by heating in the pres-
ence of glyoxal reduced the amount of product
which migrated in the region of virion RNA, but
a detectable amount of this product remained
(data not shown). Therefore, although some
small products might migrate in this region in
hydrogen-bonded structures with unlabeled tem-
plate RNA, a detectable quantity retained this
migration rate after stringent denaturation.
It was possible to increase the rate of protein
synthesis in the reaction by adding saturating
amounts of viral mRNA. Comparison of the
products synthesized in a reaction which con-
tained no added mRNA (Fig. 5, lane 3) with
those in a reaction to which mRNA had been
added to increase the rate of protein synthesis
(Fig. 5, lane 4) shows two marked differences.
Addition ofmRNA to the reaction resulted in (i)
a decrease in the amount of mRNA synthesis
and (ii) an increase in the amount of product
migrating in the region of genome-length RNA.
The intracellular templates used in the experi-
ment shown in Fig. 5 were not treated with
micrococcal nuclease. The template fraction
therefore contained viral mRNA in polysomal
aggregates, and possibly intracellular viral pro-
teins. All other experiments described in this
communication were carried out with intracellu-
lar templates prepared by treatment with micro-
coccal nuclease to make the system dependent
on the addition of exogenous mRNA for pro-
gramming of protein synthesis.
This analysis of RNA products yielded valu-
able information concerning the ability of the
system to synthesize bona fide viral RNA prod-
ucts and demonstrated a striking effect of the
level of protein synthesis on the RNA products
synthesized. However, the analysis of products
by agarose gel electrophoresis can give no infor-
mation regarding the polarity ofRNA products.
A different method of analysis was needed,
therefore, to analyze possible negative-strand
products of this system.
Analysis of RNA products by CsCl gradient
centrifugation. One of the difficulties inherent in
the attempt to analyze VSV genome RNA syn-
thesis is that transcription is by far the predomi-
nant RNA synthetic event in this system. Even
in infected cells under presumably optimal con-
ditions, replication comprises only 10% of the
viral RNA synthetic events. Therefore, to focus
on negative-strand RNA synthesis, we had to
select for replicative products of the system.
Studies ofVSV replication in infected cells have
shown that genome-size RNA of both positive
and negative polarity is present in the cell only in
the form of a nucleocapsid structure (16). It
seemed likely, therefore, that replicative prod-
ucts might be distinguished from transcriptive
products by their association with protein.
To test the possibility that replicative RNA
products synthesized in the in vitro RNA syn-
thesis system were being coated with protein,
we analyzed the products by equilibrium centrif-
ugation in CsCl. This technique cleanly sepa-
rates the protein-coated viral nucleocapsids,
which band at a density of 1.3 g/cm3, from the
mRNA's, which pellet to the bottom of the CsCl
gradient. The products synthesized in reaction
mixtures to which purified nucleocapsid tem-
plates were added in the presence or absence of
added mRNA were analyzed by centrifugation
in CsCl. The distribution of the H-labeled RNA
products after centrifugation is shown in Fig. 6.
Approximately 95% of the total product of the in
vitro system pelleted. However, a distinct peak
comprising 2 to 5% of the 3H-labeled RNA
product banded in the CsCl. This peak of labeled
product banded exactly at the position of intra-
cellular nucleocapsids when the two were ana-
lyzed by cosedimentation. The data in Fig. 6
represent analyses of reactions programmed
with templates alone (Fig. 6A) or templates plus
added mRNA (Fig. 6B). The amount of material
which pelleted through the CsCl was reduced by
approximately 50%o in the presence of added
message. In contrast, in the presence of in-
creased levels of protein synthesis, the amount
of material which banded in CsCl never de-
creased and frequently increased. These results
showed that RNA product could be recovered at
the position of nucleocapsids and thereby sepa-
rated from the mature mRNA's which, as subse-
quent results confirmed, were all in the pellet.
This CsCl-banded RNA product was a likely
candidate for the presence of negative-strand
sequences.
Analysis of RNA products: hybridization. The
RNA products separated by centrifugation in
CsCl were analyzed by RNA-RNA hybridiza-
tion, a sensitive assay for the presence of nega-
tive-sense replicative products. It was found
that all of the negative-sense RNA made in the
system was in the material that banded in CsCl
(Table 1). The material that pelleted contained
no negative-strand RNA product, only positive-
sense RNAs.
Analysis by electrophoresis in agarose gels
showed that all of the pelleted material comigrat-
ed with mature mRNA's from infected cells; no
material the size of mature mRNA banded at the
position of nucleocapsids (data not shown). The
finding that all of the negative-strand product
made in the system banded in CsCl in a manner
that clearly separated it from the completed
RNA transcriptive products which pelleted pro-
vided an excellent means of distinguishing and
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FIG. 6. Equilibrium centrifugation of RNA products in CsCl gradients. Reaction mixtures containing
13H]UTP were incubated for 90 min at 30°C, diluted into buffer containing 0.5% Nonidet P40 and layered onto
preformed 20 to 40% CsCl gradients (Materials and Methods). The gradients were centrifuged to equilibrium and
fractionated, and the pelleted material was suspended in 10mM Tris, pH 7.4, and 1 mM EDTA. A portion of each
fraction was assayed for trichloroacetic acid-insoluble counts per minute. The arrows indicate the fraction
containing cosedimented intracellular nucleocapsid markers. (A) A reaction miixture containing mRNA-
dependent reticulocyte lysate and intracellular nucleocapsids. The total number of 3H counts per minute
recovered at nucleocapsid density in this reaction was 69,000. The pellet contained 2,607,000 cpm. (B) A reaction
mixture as in A, to which approximately 120 ,ug of purified VSV mRNA's per ml was added. In this reaction
76,000 3H counts per minute were recovered at the position of nucleocapsids, and 1,146,000 3H counts per
minute were recovered in the pellet.
separating the products of transcriptive and rep-
licative events in this system.
Effect of protein synthesis on negative-strand
RNA synthesis. The ability to separate the nega-
tive-strand RNA product made in the in vitro
system from the transcriptive products and to
measure the amount of negative-strand RNA by
hybridization made it possible to examine the
effect of altered levels of protein synthesis on
the synthesis of negative-strand RNA.
The relationship between protein synthesis
and negative-strand RNA synthesis in this in
vitro system was tested by altering the levels of
protein synthesis in the reaction. In these ex-
periments the amount of negative-strand RNA
synthesized in the complete system (consisting
of nucleocapsid templates and reticulocyte ly-
sate programmed with saturating amounts of
exogenous VSV mRNA) was compared with the
products synthesized in a parallel reaction to
which cycloheximide had been added to prevent
protein synthesis, or in a reaction in which
exogenous VSV mRNA had not been added at
time zero to program protein synthesis. RNA
products from the above reactions were labeled
with [3H]UTP and separated by banding in CsCl.
The products which banded and those which
pelleted were quantitated and analyzed for their
content of negative and positive sequences by
hybridization (Table 1). It was found that 45% of
the material that banded in CsCl from the com-
plete reaction carried out in the presence of the
highest levels of protein synthesis was negative
stranded. In comparison, when protein synthe-
sis was reduced by the omission of mRNA, the
percentage of negative-strand sequences
dropped to 28%. When 97% of protein synthesis
was inhibited by the addition of cycloheximide,
only 15% of the product which banded in CsCl
was of negative-strand polarity. The increase in
the proportion of negative-strand product in the
presence of increased protein synthesis repre-
sents a net increase in the amount of negative-
strand RNA made, since the amount of material
banding of CsCl and used for hybridization in
that case was always equal to or greater than
that in the absence of added mRNA. The de-
crease in the proportion of negative-strand prod-
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TABLE 1. Analysis of RNA products separated by CsCl gradient centrifugation
cpm in Analysis of CsCl-banded RNA (cpm)b cpm in
Prepn Total cpm banded Negative Positive RNase pelleted
strandc strandc resistant RNAd
A. Templates + mRNA 1,002,200 68,780 30,050 28,720 27,380 935,400
added to the (6.7) (45) (43) (41) (93)
reaction
B. Templates alone 1,443,100 68,180 19,090 49,170 18,910 1,375,000
(4.7) (28) (73) (27) (95)
C. Templates + mRNA 1,429,400 70,000 10,500 60,900 11,200 1,359,400
+ cycloheximide (4.9) (15) (87) (16) (95)
a 3H-labeled RNA products which banded at the position of nucleocapsids in CsCl were either tested directly
for RNase resistance (Materials and Methods) or desalted, purified by phenol extraction, and used in
hybridization reactions (18). Numbers in parentheses are the percentage of the total counts per minute.
b Numbers in parentheses are the percentage of banded RNA counts per minute.
c Hybridization analysis ofRNA products. Values shown are the amount of product protected with saturating
amounts of unlabeled RNA probe. Purified mRNA and virion RNA probes were prepared as previously
described (18). Each hybridization reaction contained 2,000 to 4,000 3H counts per minute in RNA product. The
reason that 100o protection could not be achieved in all cases may be a result of the fact that the mRNA probe
was isolated by velocity sedimentation followed by chromatography on cellulose CF-11 to ensure that no
negative-strand RNA was present. Therefore, the entire complement of the genome (i.e., the small "leader" and
"trailer" RNAs) probably is not represented.
d 3H-labeled RNA products which sedimented to the bottom of the CsCl gradient were ethanol precipitated
and used in hybridization reactions. Greater than 95% of pelleted RNA products were rendered RNase resistant
by hybridization to purified virion RNA. Purified unlabeled mRNA was unable to protect any counts from RNase
digestion in a parallel hybridization. Numbers in parentheses are the percentage of the total counts per minute.
uct in the presence of cycloheximide also repre-
sents a net decrease in the production of
negative-stranded RNA, since the amount of
CsCl-banded RNA product was never greater
than that produced in the reaction without cyclo-
heximide.
These results show: (i) that significant quanti-
ties of negative-strand, genome-sense RNA are
being synthesized in this in vitro system, (ii) that
all of the progeny negative-strand RNA is band-
ing in CsCl at the position of nucleocapsids, and
(iii) that the level of negative-strand products
synthesized in the system is a function of the
amount of concurrent protein synthesis in the
system. An increase in the amount of viral
protein synthesis leads to an increase in the
amount of negative-strand RNA that is being
made.
In contrast to the increase in negative-strand
RNA synthesis in the presence of increased
protein synthesis, it was observed that the total
amount ofRNA synthesis decreased under these
same conditions (Fig. 4, curves A and C). That
this was a specific inhibition of transcription is
supported by the data presented in Fig. 5, lanes
3 and 4, and by the analysis of product on CsCl
gradients (Fig. 6), which showed a 50% decrease
in the amount of peileted material, containing
only mRNA products, in the presence of in-
creased protein synthesis. In other experiments
it was shown that the addition of cycloheximide
to the system partially reversed this inhibition
(Fig. 4, curve B). Cycloheximide treatment in-
creased the amount of 3H-labeled mRNA prod-
ucts which pelleted through CsCl (1.2 x 106
cpm) as compared with the amount of pelleted
RNA product made in a parallel reaction mix-
ture containing exogenous mRNA but no cyclo-
heximide (0.8 x 106 cpm). Thus, the inhibition of
total RNA synthesis by increased levels of pro-
tein synthesis reflects a specific inhibition of
transcription which is partially reversed in the
presence of cycloheximide.
The banding of the negative-strand RNA
products in CsCl at the position of nucleocapsids
and the stimulation of genome RNA synthesis
by increased protein synthesis suggested that
these RNAs might be associated with viral pro-
tein in an RNase-resistant structure similar to
that of the mature nucleocapsid. To test this
hypothesis, we tested the CsCl-banded RNA
products for their resistance to digestion with
pancreatic RNase (Table 1). A control prepara-
tion of naked, purified virion RNA analyzed at
the same time was completely digested under
the conditions used in these experiments. A
comparison of the CsCl-banded RNA products
from the three different reaction mixtures de-
scribed in Table 1 demonstrated a close correla-
tion between the percentage of product which is
negative stranded and the percentage which is
RNase resistant. Taken together, these data
show that higher levels of protein synthesis in
the system were associated with an increased
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amount of negative-strand RNA synthesis and
an increased amount of RNase-resistant prod-
uct.
Identification of genomic sequences present in
negative-strand product. After we had deter-
mined that negative-strand RNA was being syn-
thesized in the system, the next important ques-
tion was to identify what regions of the genome
were being replicated so that we could deter-
mine whether the negative-strand product repre-
sented sequences from all regions of the
genome. To test this possibility, we labeled
RNA products synthesized in a 90-min reaction
in the complete system with [a-32P]UTP. The
labeled negative-strand product was separated
from the majority of the transcriptive products
by affinity chromatography on oligo(dT)-cellu-
lose. The unbound RNA, which contained all of
the negative-strand sequences, was subjected to
limited treatment with NaOH to produce mole-
cules no larger than 500 to 1,000 nucleotides.
This labeled product was then hybridized to the
five VSV mRNA's which had been separated by
electrophoresis and transferred by Northern blot-
ting techniques to diazobenzyloxymethyl paper.
As shown by the data presented in Fig. 7 (lane
1), labeled product annealed to all five of the
VSV mRNA's. The observation that the amount
of probe hybridized to the L mRNA appears less
than that annealed to the other messages does
not indicate that there is less product from that
region. Rather, this is a result of the fact that less
L mRNA than the other mRNA's was trans-
ferred to diazobenzyloxymethyl paper. This is
confirmed by the control (Fig. 7, lane 2), which
shows that similar proportions of uniformly la-
beled 32P-virion RNA are hybridized to the
mRNA's under identical conditions of hybrid-
ization. A control experiment demonstrating the
specificity of hybridization in this system is
shown in Fig. 7, lane 3, where the 32P-labeled
oligo(dT)-bound products made in the system
were annealed to diazobenzyloxymethyl-bound
unlabeled mRNA. As is clearly shown, no hy-
bridization occurred.
The results of these experiments show that
RNA product complementary to all five of the
VSV mRNA's, and, hence, product from all of
the genes is being synthesized in vitro.
DISCUSSION
The results presented in this communication
describe the synthesis of VSV negative-strand
RNA in an in vitro system. This is the first
report of a cell-free system in which negative-
strand RNA synthesis is controlled, as it is in the
infected cell, by the level of attendant protein
synthesis. The major components of the system
are an mRNA-dependent rabbit reticulocyte ly-





FIG. 7. 32P-labeled RNA product used to probe a
Northern blot of purified VSV mRNAs. RNA was
labeled with [a-32P]UTP in cell-free reactions contain-
ing mRNA-dependent reticulocyte lysate, intracellular
nucleocapsids, purified VSV mRNA's, and other com-
ponents as described in Materials and Methods. 32p_
labeled RNA products were purified by phenol extrac-
tion, precipitated with ethanol, and chromatographed
on oligo(dT)-cellulose. Lane 1: hybridization of RNAs
which did not bind to oligo(dT)-cellulose, and which
contained all of the negative-strand RNA product, to a
Northern blot of electrophoretically separated VSV
mRNAs. Lane 2: hybridization of excess 32P-uniform-
ly labeled VSV virion RNA to an identical blot ofVSV
mRNA as a control to demonstrate the relative
amounts of the VSV mRNA's bound to the diazoben-
zyloxymethyl paper. Lane 3: hybridization of 32p_
labeled oligo(dT)-bound RNA synthesized in vitro
which contained only mature polyadenlated VSV
mRNA's to an identical blot.
capsids. The system is able to synthesize all five
viral proteins in response to addition of the five
viral mRNA's. Template-dependent RNA syn-
thesis in this system produces the five polyad-
enylated VSV mRNA's and, in addition, nega-
tive-strand RNA.
The experiments described show that in-
creased viral protein synthesis in the in vitro
reaction leads to increased negative-strand RNA
synthesis. This same increase in protein synthe-
sis also results in a 30 to 50% reduction in
mRNA synthesis. Conversely, the reduction of
protein synthesis by 97% in the presence of
cycloheximide leads to a 70% decrease in the
amount of negative-strand RNA synthesized
while stimulating mRNA synthesis by 30 to 50%.
These results show that factors involved in the
regulation of transcription and the promotion of
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negative-strand genome RNA synthesis are op-
erating in this system.
A striking finding is that not only are negative-
strand, genome-sense sequences made in this
system, but, in contrast to the mRNA products,
all of the negative-strand RNA product bands in
CsCl gradients at the position of viral nucleocap-
sids. RNA products which band at the equilibri-
um density of nucleocapsids represent 2 to 5% of
the total RNA made in the system, and as much
as 45% of this RNA is in negative-strand se-
quences. The finding that the genome-sense
RNA products, unlike the mRNA products,
band at the position of nucleocapsids and that
their synthesis is dependent on protein synthesis
suggests that they have associated, in vitro, with
the viral proteins also being synthesized in the
system. Support for this suggestion comes from
the finding that a significant fraction of these
banded RNA products are resistant to RNase.
Indeed, the percentage of RNase resistance of
the RNA products in the nucleocapsid band
correlates very closely with the percentage of
RNA products which are negative-stranded.
Further experiments are required, however, to
determine whether all of the negative-strand
RNA which bands at the position of nucleocap-
sids is present in an RNase-resistant structure
containing viral proteins. Positive-stranded
RNA sequences are also found in the material
which bands in CsCl. At present, it has not been
determined whether this material represents im-
mature template-associated mRNA's which are
susceptible to RNase digestion or, possibly, the
synthesis of positive-strand nucleocapsid tem-
plates. We do know, however, that the products
which band in CsCl do not include material
which migrates as mature mRNA when this
material is analyzed by gel electrophoresis. All
mature RNA that is synthesized in this system
pellets in CsCl.
We have estimated that an average of 10 pmol
of viral protein is synthesized in the 50-,ul reac-
tion mixture. This estimate is derived from the
specific activity of the [35S]methionine (assum-
ing the lysate to contain 9.2 ,uM methionine [15]),
the relative amounts of each mRNA added (as-
suming that each mRNA is translated with equal
efficiency), and the known methionine content
of the four small viral proteins (21). A similar
calculation leads to an estimate of 0.5 to 1.3
pmol for the amount of mRNA synthesized in
the 50-pJ reaction mixture. Data presented here
have shown that negative-strand RNA synthesis
represents approximately 2.5% of mRNA syn-
thesis. Therefore, viral protein is made in much
larger quantities than the estimated amounts of
negative-strand RNA. Studies of viral nucleo-
capsid structure have indicated that approxi-
mately 1,000 to 2,000 N proteins are associated
with the genome-length RNA (12). Our rough
calculations serve to point out that the ratio of
newly made viral proteins to negative-strand
RNA synthesized in the system is sufficiently
high to permit their association in a nucleocap-
sid-type structure.
Northern blot analysis of the negative-strand
RNA products made in the system showed that
this product contained sequences complemen-
tary to all of the five viral mRNA's including the
L mRNA which is complementary to the 5'
region of the genome RNA. These results dem-
onstrate that negative-strand product is being
synthesized from all cistrons of the genome and
that the negative-strand product is not confined
to a particular region. The product does not
merely represent, for example, synthesis of only
a small region of the genome.
At present, we do not know whether initiation
of negative-strand synthesis is occurring in this
system. The templates used are intracellular
nucleocapsids which have been prepared by
using micrococcal nuclease treatment to remove
exogenous non-protein-coated RNAs. It is pos-
sible that these templates may contain nascent
progeny RNA molecules which remain attached
to the template or that the nascent chains may
have been clipped off during template purifica-
tion. Therefore, it is possible that the product
made could represent (i) de novo synthesis from
the 3' end of the template, (ii) elongation of
attached nascent strands, (iii) synthesis of RNA
by polymerase molecules that remain attached
along the template even though nascent tails
may have been removed during template purifi-
cation, or (iv) any combination of the above.
Although it is not possible to discriminate among
these possibilities at this time, data presented
here show that label is incorporated into materi-
al that migrates in agarose gels at the position of
genome RNA, and Northern blot analysis of
product demonstrates that product is being syn-
thesized from all cistrons of the genome. Further
experiments will be required to demonstrate
whether initiation, elongation, and completion
of genome-size, negative-stranded RNA are oc-
curring in this system.
The system described here is similar in con-
cept to cell-free systems described previously
for the synthesis of VSV RNAs and proteins (3,
4, 6). In contrast to previous systems, however,
there are three differences in the present system
that should be noted. First, intracellular nucleo-
capsids containing both negative-strand and pos-
itive-strand RNA are used as templates for viral
RNA synthesis instead of mature virions or
virion nucleocapsids. The 10 to 20% of these
nucleocapsids which contain positive-strand
RNA are capable of serving directly as tem-
plates for the synthesis of progeny genomes.
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This is in contrast to former situations in which
negative-strand RNA synthesis could not be
initiated until an active positive-strand nucleo-
capsid template was made. Second, previous
reports described "coupled" systems in which
the synthesis of viral proteins relied on newly
synthesized mRNA to program the translational
machinery. Data presented here show that the
addition of purified mRNA's to the in vitro
system, especially at early times in the incuba-
tion, greatly increases the level of viral protein
synthesis. The levels of protein synthesis in the
system directly correlate with the levels of nega-
tive-strand RNA that can be made in the system.
Third, the separation of the RNA products by
equilibrium centrifugation in CsCl has allowed a
significant enrichment for negative-strand prod-
ucts in the nucleocapsid band. Quantitative
studies and molecular characterization of the
genome-sense RNA can now be carried out in
the absence of the large background of transcrip-
tive products.
The system described here demonstrates not
only that negative-strand RNA synthesis can be
carried out in vitro but also that the synthesis of
negative-strand RNA and the relative levels of
transcription and replication are dependent upon
the level of viral protein synthesis programmed
in the system. The negative-strand product
made bands in CsCl at the position of viral
nucleocapsids and contains sequences from all
five viral genes. This translation-assisted, cell-
free system for VSV RNA synthesis provides a
unique opportunity to study the factors involved
in the promotion and regulation of RNA synthe-
sis. Each of the viral proteins can be synthesized
in response to purified mRNA's added individ-
ually to the in vitro system. Therefore, this
system provides a means of testing the relation-
ship of each of the viral proteins to RNA synthe-
sis by programming the in vitro system with the
individual mRNA's. These studies are currently
underway.
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